Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases

Frontiers in Cardiovascular Medicine

Volumn 2, Issue , 2015, Pages

  Kakoti, Bibhuti Bhusan ^a   Hernandez Ontiveros, Diana G ^b   Kataki, Manjir Sarma ^a   Shah, Kajri ^b   Pathak, Yashwant ^b   Panguluri, Siva Kumar ^b  

^a DIBRUGARH UNIVERSITY   (India)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

cardiovascular diseases; coronary artery diseases; endoplasmic reticulum stress; omega 3 fatty acid; oxidative stress; resveratrol

Indexed keywords

EID: 84981255322     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2015.00038     Document Type: Review

References (78)

1. Centers for Disease Control and Prevention; National Center for Health Statistics. Underlying Cause of Death 1999-2013. Data Are from the Multiple Cause of Death Files, 1999-2013, as Compiled from Data Provided by the 57 Vital Statistics Jurisdictions Through the Vital Statistics Cooperative Program (2015). Available from: http://wonder.cdc.gov/ucd-icd10.html
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 111:1448–54.10.1161/01.CIR.0000158483.13093.9D
3. Peairs AD, Rankin JW, Lee YW. Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults. Nutr J (2011) 10:122.10.1186/1475-2891-10-12222059644
4. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol (2006) 26:995–1001.10.1161/01.ATV.0000214295.86079.d116484595
5. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr (2005) 82:222S–5S.16002825
6. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPX1) and Nadph oxidase subunit (NOX4). J Physiol Pharmacol (2009) 60:111–6.20083859
7. Borrelli F, Capasso R, Izzo AA. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res (2007) 51:1386–97.10.1002/mnfr.20070007217918162
8. Vidavalur R, Otani H, Singal PK, Maulik N. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol (2006) 11:217–25.18651034
9. Yang T, Wang L, Zhu M, Zhang L, Yan L. Properties and molecular mechanisms of resveratrol: a review. Pharmazie (2015) 70:501–6.10.1691/ph.2015.557126380517
10. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 9:257–88.10.1146/annurev.bioeng.9.060906.152025
11. Niemeyer CM. Semi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnology. J Biotechnol (2001) 82:47–66.10.1016/S1389-0352(01)00027-711999713
12. Nishiyama N. Nanomedicine: nanocarriers shape up for long life. Nat Nanotechnol (2007) 2:203–4.10.1038/nnano.2007.88
13. Shutava TG, Balkundi SS, Vangala P, Steffan JJ, Bigelow RL, Cardelli JA, et al. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano (2009) 3:1877–85.10.1021/nn900451a19534472
14. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 5:161–71.10.1038/nrc156615738981
15. Wang X, Yang L, Chen ZG, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin (2008) 58:97–110.10.3322/CA.2007.0003
16. McNeil SE. Nanoparticle therapeutics: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2009) 1:264–71.10.1002/wnan.620049796
17. Jagtap S, Meganathan K, Wagh V, Winkler J, Hescheler J, Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr Med Chem (2009) 16:1451–62.10.2174/09298670978790957819355899
18. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer (2011) 11:211–8.10.1038/nrc301721326325
19. Nair HB, Sung B, Yadav VR, Kannappan R, Chaturvedi MM, Aggarwal BB. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol (2010) 80:1833–43.10.1016/j.bcp.2010.07.02120654584
20. Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res (2009) 69:1712–6.10.1158/0008-5472.CAN-08-397819223530
21. Barras A, Mezzetti A, Richard A, Lazzaroni S, Roux S, Melnyk P, et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm (2009) 379:270–7.10.1016/j.ijpharm.2009.05.05419501139
22. Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, et al. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem (2011) 54:1321–32.10.1021/jm101371521306166
23. Yadav VR, Aggarwal BB. Curcumin: a component of the golden spice, targets multiple angiogenic pathways. Cancer Biol Ther (2011) 11:236–41.10.4161/cbt.11.2.14405
24. Dube A, Nicolazzo JA, Larson I. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechingallate. Eur J Pharm Sci (2010) 41:219.10.1016/j.ejps.2010.06.01020600878
25. Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer (2014) 21:R209–25.10.1530/ERC-13-017124500760
26. Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity – a review. Nutrients (2010) 2:1212–30.10.3390/nu212121222254005
27. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging (2004) 8:163–74.10.1186/1476-511X-3-2515129302
28. Holman RT. The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr (1998) 128:427S–33S.9478042
29. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res (2006) 99:275–82.10.1161/01.RES.0000233317.70421.0316794188
30. Pan YX, Lin L, Ren AJ, Pan XJ, Chen H, Tang CS, et al. HSP70 and GRP78 induced by endothelin-1 pretreatment enhance tolerance to hypoxia in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol (2004) 44(Suppl 1):S117–20.10.1097/01.fjc.0000166234.11336.a915838258
31. Vitadello M, Penzo D, Petronilli V, Michieli G, Gomirato S, Menabo R, et al. Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J (2003) 17:923–5.10.1096/fj.02-0644fje12670879
32. Severino A, Campioni M, Straino S, Salloum FN, Schmidt N, Herbrand U, et al. Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol (2007) 50:1029–37.10.1016/j.jacc.2007.06.00617825711
33. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol (2003) 5:781–92.10.1038/ncb103512907943
34. Zhou J, Lhoták Š, Hilditch BA, Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation (2005) 111:1814–21.10.1161/01.CIR.0000160864.31351.C1
35. Myoishi M, Hao H, Minamino T, Watanabe K, Nishihira K, Hatakeyama K, et al. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation (2007) 116:1226–33.10.1161/CIRCULATIONAHA.106.68205417709641
36. Digaleh H, Kiaei M, Khodagholi F. Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagy. Cell Mol Life Sci (2013) 70:4681–94.10.1007/s00018-013-1409-y23800989
37. Lee S, Hur EG, Ryoo IG, Jung KA, Kwak J, Kwak MK. Involvement of the Nrf2-proteasome pathway in the endoplasmic reticulum stress response in pancreatic beta-cells. Toxicol Appl Pharmacol (2012) 264:431–8.10.1016/j.taap.2012.08.021
38. Cominacini L, Mozzini C, Garbin U, Pasini A, Stranieri C, Solani E, et al. Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. Free Radic Biol Med (2015) 88(Pt B):233–42.10.1016/j.freeradbiomed.2015.05.02726051167
39. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci (2011) 1215:22–33.10.1111/j.1749-6632.2010.05843.x
40. Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M, et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res (2010) 86:103–12.10.1093/cvr/cvp38419959541
41. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev (2004) 22:169–88.10.1111/j.1527-3466.2004.tb00139.x15492766
42. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (review). Int J Mol Med (2001) 8:3–17.10.3892/ijmm.8.1.311408943
43. Tang PC, NG YF, HO S, Gyda M, Chan SW. Resveratrol and cardiovascular health – promising therapeutic or hopeless illusion? Pharmacol Res (2014) 90:88–115.10.1016/j.phrs.2014.08.001
44. Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C, et al. Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: role of the TLR4/NF-kappaB signaling pathway. Mol Med Rep (2015) 11(2):1120–6.10.3892/mmr.2014.2955
45. Weaver J, Liu KJ. Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. Med Gas Res (2015) 5:015–0032.10.1186/s13618-015-0032-426306184
46. Saita E, Kondo K, Momiyama Y. Anti-inflammatory diet for atherosclerosis and coronary artery disease: antioxidant foods. Clin Med Insights Cardiol (2015) 8:61–5.10.4137/CMC.S1707126279633
47. Nabavi SF, Li H, Daglia M, Nabavi SM. Resveratrol and stroke: from chemistry to medicine. Curr Neurovasc Res (2014) 11:390–7.10.2174/156720261166614091211483325219659
48. Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”. Semin Thromb Hemost (2010) 36:59–70.10.1055/s-0030-124872520391297
49. Fagherazzi G, Vilier A, Lajous M, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, et al. Wine consumption throughout life is inversely associated with type 2 diabetes risk, but only in overweight individuals: results from a large female French cohort study. Eur J Epidemiol (2014) 29:831–9.10.1007/s10654-014-9955-725270278
50. Al-Harthi SE, Alarabi OM, Ramadan WS, Alaama MN, Al-Kreathy HM, Damanhouri ZA, et al. Amelioration of doxorubicin-induced cardiotoxicity by resveratrol. Mol Med Rep (2014) 10:1455–60.10.3892/mmr.2014.2384
51. Arafa MH, Mohammad NS, Atteia HH, Abd-Elaziz HR. Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. J Physiol Biochem (2014) 70:701–11.10.1007/s13105-014-0339-y24939721
52. Lamptey MS, Walker BL. A possible essential role for dietary linolenic acid in the development of the young rat. J Nutr (1976) 106:86–93.942747
53. Bacarin CC, De Sa-Nakanishi AB, Bracht A, Matsushita M, Previdelli IS, Mori MA, et al. Fish oil prevents oxidative stress and exerts sustained antiamnesic effect after global cerebral ischemia. CNS Neurol Disord Drug Targets (2015) 14(3):400–10.10.2174/187152731466615022512523225714977
54. Darghosian L, Free M, Li J, Gebretsadik T, Bian A, Shintani A, et al. Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am J Cardiol (2015) 115:196–201.10.1016/j.amjcard.2014.10.02225465932
55. Jain AP, Aggarwal KK, Zhang PY. Omega-3 fatty acids and cardiovascular disease. Eur Rev Med Pharmacol Sci (2015) 19:441–5.25720716
56. McEwen BJ, Morel-Kopp MC, Tofler GH, Ward CM. The effect of omega-3 polyunsaturated fatty acids on fibrin and thrombin generation in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost (2015) 41(3):315–22.10.1055/s-0034-139535225703517
57. Nigam A, Talajic M, Roy D, Nattel S, Lambert J, Nozza A, et al. Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J Am Coll Cardiol (2014) 64:1441–8.10.1016/j.jacc.2014.07.95625277614
58. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr (2012) 107(Suppl 2):S201–13.10.1017/S000711451200159622591894
59. GISSI. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico). Lancet (1999) 354:447–55.10.1016/S0140-6736(99)07072-5
60. Da Cunha NV, Pinge-Filho P, Panis C, Silva BR, Pernomian L, Grando MD, et al. Decreased endothelial nitric oxide, systemic oxidative stress, and increased sympathetic modulation contribute to hypertension in obese rats. Am J Physiol Heart Circ Physiol (2014) 306:H1472–80.10.1152/ajpheart.00520.201324633548
61. Herrera EA, Farias JG, Gonzalez-Candia A, Short SE, Carrasco-Pozo C, Castillo RL. Omega3 supplementation and intermittent hypobaric hypoxia induce cardioprotection enhancing antioxidant mechanisms in adult rats. Mar Drugs (2015) 13:838–60.10.3390/md13020838
62. Gorjao R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, Procopio J, et al. Comparative effects of DHA and EPA on cell function. Pharmacol Ther (2009) 122:56–64.10.1016/j.pharmthera.2009.01.00419318040
63. Liu Y, Chen LY, Sokolowska M, Eberlein M, Alsaaty S, Martinez-Anton A, et al. The fish oil ingredient, docosahexaenoic acid, activates cytosolic phospholipase A(2) via GPR120 receptor to produce prostaglandin E(2) and plays an anti-inflammatory role in macrophages. Immunology (2014) 143:81–95.10.1111/imm.12296
64. Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther (2014) 141:272–82.10.1016/j.pharmthera.2013.10.01024201219
65. Balakumar P, Taneja G. Fish oil and vascular endothelial protection: bench to bedside. Free Radic Biol Med (2012) 53:271–9.10.1016/j.freeradbiomed.2012.05.00522584102
66. Al-Khalifa A, Maddaford TG, Chahine MN, Austria JA, Edel AL, Richard MN, et al. Effect of dietary hempseed intake on cardiac ischemia-reperfusion injury. Am J Physiol Regul Integr Comp Physiol (2007) 292:R1198–203.10.1152/ajpregu.00661.200617122327
67. Bellido C, Lopez-Miranda J, Blanco-Colio LM, Perez-Martinez P, Muriana FJ, Martin-Ventura JL, et al. Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men. Am J Clin Nutr (2004) 80:1487–91.15585759
68. Schwager J, Richard N, Riegger C, Salem N, Jr. Omega-3 PUFAs and resveratrol differently modulate acute and chronic inflammatory processes. Biomed Res Int (2015) 2015:535189.10.1155/2015/535189
69. Schwager J, Richard N, Schoop R, Wolfram S. A novel rose hip preparation with enhanced anti-inflammatory and chondroprotective effects. Mediators Inflamm (2014) 2014:105710.10.1155/2014/10571025371599
70. Shen CL, Dunn DM, Henry JH, Li Y, Watkins BA. Decreased production of inflammatory mediators in human osteoarthritic chondrocytes by conjugated linoleic acids. Lipids (2004) 39:161–6.10.1007/s11745-004-1214-615134143
71. Hobbs T, Caso R, McMahon D, Nymark M. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Altern Ther Health Med (2014) 20:18–23.25141367
72. WHO. Interventions on Diet and Physical Activity: What Works: Summary Report. Geneva: World Health Organization (2009).
73. Huhn S, Kharabian Masouleh S, Stumvoll M, Villringer A, Witte AV. Components of a Mediterranean diet and their impact on cognitive functions in aging. Front Aging Neurosci (2015) 7:132.10.3389/fnagi.2015.0013226217224
74. Couto E, Boffetta P, Lagiou P, Ferrari P, Buckland G, Overvad K, et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 104:1493–9.10.1038/bjc.2011.10621468044
75. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Fung TT, Li S, Willett WC, et al. The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am J Clin Nutr (2014) 99:172–80.10.3945/ajcn.113.06810624172306
76. Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology (2013) 24:479–89.10.1097/EDE.0b013e318294441023680940
77. Valls-Pedret C, Ros E. Commentary: Mediterranean diet and cognitive outcomes: epidemiological evidence suggestive, randomized trials needed. Epidemiology (2013) 24:503–6.10.1097/EDE.0b013e318296bf8e
78. Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, DE LA, Torre R. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med (2015) 175:1094–103.10.1001/jamainternmed.2015.166825961184